Changes in physical function and quality of life and cost-effectiveness of rehabilitation in patients with hematopoietic tumors
Not Applicable
- Conditions
- Patients with hematopoietic tumors
- Registration Number
- JPRN-UMIN000050074
- Lead Sponsor
- St. Marianna university of medicine Yokohama Seibu hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients who died during the course of hospitalization or during the study period (2) Patients whose level of consciousness or general condition deteriorated during the course of hospitalization or during the study period and for whom rehabilitation evaluation could not be performed. (3) Patients who could not give consent for this study and rehabilitation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie rehabilitation efficacy in hematopoietic tumor patients?
How does rehabilitation compare to standard-of-care in improving physical function for hematopoietic malignancies?
Which biomarkers correlate with response to rehabilitation in hematopoietic tumor survivors?
What adverse events are associated with rehabilitation programs in hematopoietic cancer patients?
Are there combination therapies enhancing rehabilitation outcomes in hematopoietic tumor treatment?